PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma

PAF1c 将胰腺癌中的 S 期进程与免疫逃逸和 MYC 功能联系起来

阅读:2
作者:Abdallah Gaballa #,Anneli Gebhardt-Wolf #,Bastian Krenz,Greta Mattavelli,Mara John,Giacomo Cossa,Silvia Andreani,Christina Schülein-Völk,Francisco Montesinos,Raphael Vidal,Carolin Kastner,Carsten P Ade,Burkhard Kneitz,Georg Gasteiger,Peter Gallant,Mathias Rosenfeldt,Angela Riedel,Martin Eilers

Abstract

In pancreatic ductal adenocarcinoma (PDAC), endogenous MYC is required for S-phase progression and escape from immune surveillance. Here we show that MYC in PDAC cells is needed for the recruitment of the PAF1c transcription elongation complex to RNA polymerase and that depletion of CTR9, a PAF1c subunit, enables long-term survival of PDAC-bearing mice. PAF1c is largely dispensable for normal proliferation and regulation of MYC target genes. Instead, PAF1c limits DNA damage associated with S-phase progression by being essential for the expression of long genes involved in replication and DNA repair. Surprisingly, the survival benefit conferred by CTR9 depletion is not due to DNA damage, but to T-cell activation and restoration of immune surveillance. This is because CTR9 depletion releases RNA polymerase and elongation factors from the body of long genes and promotes the transcription of short genes, including MHC class I genes. The data argue that functionally distinct gene sets compete for elongation factors and directly link MYC-driven S-phase progression to tumor immune evasion.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。